StockData
Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc. (ANIK) stock

ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/30
$13.62+0.77 (+5.99%)

Close on Nov 18, 2026Market cap $182.28MP/E –Yield –

Anika Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Anika Therapeutics's pe ratio was 76.9× on Apr 29, 2022, against 18.9× a year earlier. Over the last 5 years it ranged from 15.3× to 116.1×, with a median of 24.1×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Apr 29, 202276.9×+36.1
2020Oct 30, 202040.8×+17.0
2019Dec 31, 201923.8×−2.5
2018Dec 31, 201826.3×+0.9
2017Dec 29, 201725.3×+4.3
2016Dec 30, 201621.0×−0.2
2015Dec 31, 201521.2×+4.3
2014Dec 31, 201416.9×−13.6
2013Dec 31, 201330.5×+16.7
2012Dec 31, 201213.8×−5.4
2011Dec 30, 201119.2×−1.6
2010Dec 31, 201020.8×–

More Anika Therapeutics figures

See a number that looks wrong?